Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Progressive Care Inc. Announces March Sales and Issues Acquisition Update | ||
By: Nasdaq / GlobeNewswire - 23 Apr 2019 | Back to overview list |
|
MIAMI, April 23, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced further growth year-over-year in revenue and number of prescriptions filled for March 2019. In March, the company reported an 18% increase in prescriptions filled when compared to the same month last year, totaling nearly 27,000 prescriptions generating approximately $1.75 million in net revenue exclusive of PBM fees. Prescriptions filled have increased year over year for the last 18 months as a result of concentrated efforts to promote quality services to new entities including Management Services Organizations (MSOs) and large scale physicians’ practices. Industry wide reimbursement contraction and additional fees has continued to put pressure on net revenues. The Company is moving forward on monetizing core competencies such as B2B services in the healthcare industry and personalized medicinal solutions to insulate the operation from further cost cutting efforts by insurance companies and delivering profitability. “Progressive Care’s March sales and prescription numbers are a result of our dedicated commitment to providing patients with a range of personalized medication therapies,” said S. Parikh Mars, Chief Executive Officer of Progressive Care Inc. “We are confident in our ability to continue to meet our patients’ needs by providing quality healthcare management services. We look forward to continuing to break company records as the year progresses.” Update on Acquisition For more information about Progressive Care, please visit the company’s website. Connect and stay in touch with us on social media: Progressive Care Inc. PharmCo, LLC About Progressive Care Inc. Cautionary Statement Regarding Forward-Looking Statements Investor Relations Contact: Public Relations Contact: Web and Application Development Contact: |
||
|
||
Copyright 2019 Nasdaq / GlobeNewswire | Back to overview list |